Skip to main content
OpenTrials

Clinical trial condition

Chronic Spontaneous Urticaria

Explore clinical trials studying Chronic Spontaneous Urticaria. Study availability and eligibility vary by location and protocol.

70 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Chronic Spontaneous Urticaria trial results

Completed

A Phase III Study of and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines.

NCT03580356

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Allervie Clinical Research Birmingham, Alabama, United States
  • Medical Resch of Arizona-Div of Allergy Asthma and Immunology Scottsdale, Arizona, United States
  • Atria Clinical Research Asthma and Allergy Institute Little Rock, Arkansas, United States
  • DeMera Allergy Asthma and Immun Ctr Fresno, California, United States
View all 183 locations
View Trial Details
Completed

A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases

NCT05960708

Conditions
Allergic Disease, Chronic Disease, Chronic Inducible Urticaria, +13 more
Locations
  • Hallym University Sacred Heart Hospital Anyang-si, Gyeonggi-do, South Korea
  • Hallym University Dongtan Sacred Heart Hospital Hwaseong-si, Gyeonggi-do, South Korea
  • CHA Bundang Medical Center Seongnam-si, Gyeonggi-do, South Korea
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
View Trial Details
Completed

A Phase 2a Study of TAS5315 in Patients With Chronic Spontaneous Urticaria

NCT05335499

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • A site selected by Taiho Pharmaceutical Co., Ltd. Ehime, Japan
  • A site selected by Taiho Pharmaceutical Co., Ltd. Fukuoka, Japan
  • A site selected by Taiho Pharmaceutical Co., Ltd. Gunma, Japan
  • A site selected by Taiho Pharmaceutical Co., Ltd. Hiroshima, Japan
View Trial Details
Completed

An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of LOU064 in Subjects With CSU

NCT04109313

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Novartis Investigative Site Litchfield Park, Arizona, United States
  • Novartis Investigative Site Little Rock, Arkansas, United States
  • Novartis Investigative Site Mission Viejo, California, United States
  • Novartis Investigative Site San Diego, California, United States
View all 69 locations
View Trial Details
Completed

A Phase III Study of Safety and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines

NCT03580369

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Novartis Investigative Site Gilbert, Arizona, United States
  • Novartis Investigative Site Litchfield Park, Arizona, United States
  • Novartis Investigative Site Scottsdale, Arizona, United States
  • Novartis Investigative Site Little Rock, Arkansas, United States
View all 161 locations
View Trial Details
Completed

A Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria

NCT04538794

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Clinical Research Center of Alabama Birmingham, Alabama, United States
  • Arizona Allergy & Immunology Research Gilbert, Arizona, United States
  • Sarasota Clinical Research Sarasota, Florida, United States
  • ForCare Clinical Research Tampa, Florida, United States
View all 14 locations
View Trial Details
Completed

This Was a Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines

NCT03926611

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Novartis Investigative Site Litchfield Park, Arizona, United States
  • Novartis Investigative Site Little Rock, Arkansas, United States
  • Novartis Investigative Site Mission Viejo, California, United States
  • Novartis Investigative Site San Diego, California, United States
View all 82 locations
View Trial Details
Completed

Dupilumab in Chronic Spontaneous Urticaria

NCT03749135

Conditions
Angioedema, Cardiovascular Diseases, Chronic Disease, +17 more
Locations
  • Universitätsklinikum Giessen und Marburg Marburg, Hesse, Germany
  • Hautklinik Universitätsklinikum Münster Münster, NRW, Germany, Germany
  • Hautklinik der Universitätsmedizin Mainz Clinical Research Center Mainz, Rheinland-Pfalz, Germany, Germany
  • Universitätsklinikum Carl Gustav Carus Dresden, Saxony, Germany
View Trial Details

Related conditions